Private equity in ophthalmology and optometry: a time series analysis from 2012 to 2021
Article Sidebar
Main Article Content
Abstract
Purpose
To identify temporal and geographic trends in private equity (PE)–backed acquisitions of ophthalmology and optometry practices in the United States from 2012 to 2021.
Methods
In this cross-sectional time series, acquisition data from 10/21/2019 to 9/1/2021 and previously published data from 1/1/2012 to 10/20/2019 were analyzed. Acquisition data were compiled from 6 financial databases, 5 industry news outlets, and publicly available press releases. Linear regression models were used to compare rates of acquisition. Outcomes included number of total acquisitions, practice type, locations, provider details, and geographic footprint.
Results
A total of 245 practices associated with 614 clinical locations and 948 ophthalmologists or optometrists were acquired by 30 PE-backed platform companies between 10/21/2019 and 9/1/2021. Of 30 platform companies, 18 were new vis-à-vis our prior study. Of these acquisitions, 127 were comprehensive practices, 29 were retina practices, and 89 were optometry practices. From 2012 to 2021, monthly acquisitions increased by 0.947 acquisitions per year (P < 0.001*). Texas, Florida, Michigan, and New Jersey were the states with the greatest number of PE acquisitions, with 55, 48, 29, and 28 clinic acquisitions, respectively. Average monthly PE acquisitions were 5.71 per month from 1/1/2019 to 2/29/2020 (pre-COVID), 5.30 per month from 3/1/2020 to 12/31/2020 (COVID pre-vaccine [P = 0.81]), and 8.78 per month from 1/1/2021 to 9/1/2021 (COVID post-vaccine [P = 0.20]).
Conclusions
PE acquisitions increased during the period 2012-2021 as companies continue to utilize regionally focused strategies for acquisitions.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Nie J, Demkowicz PC, Hsiang W, et al. Urology practice acquisitions by private equity firms from 2011–2021. Urol Prac 2022;9:17-24. DOI: https://doi.org/10.1097/UPJ.0000000000000269
Gilreath M, Morris S, Brill JV. Physician practice management and private equity: market forces drive change. Clin Gastroenterol Hepatol 2019;17:1924-8.e2. DOI: https://doi.org/10.1016/j.cgh.2019.05.001
Robbins CJ, Rudsenske T, Vaughan JS. Private equity investment in health care services. Health Aff (Millwood) 2008;27:1389-98. DOI: https://doi.org/10.1377/hlthaff.27.5.1389
Tan S, Seiger K, Renehan P, Mostaghimi A. Trends in private equity acquisition of dermatology practices in the United States. JAMA Dermatol 2019;155:1013-21. DOI: https://doi.org/10.1001/jamadermatol.2019.1634
Fleishon HB, Vijayasarathi A, Pyatt R, Schoppe K, Rosenthal SA, Silva E 3rd. White paper: corporatization in radiology. J Am Coll Radiol 2019;16:1364-74. DOI: https://doi.org/10.1016/j.jacr.2019.07.003
Gilreath M, Patel NC, Suh J, Brill JV. Gastroenterology physician practice management and private equity: thriving in uncertain times. Clin Gastroenterol Hepatol 2021;19:1084-87. DOI: https://doi.org/10.1016/j.cgh.2021.03.015
Chen EM, Cox JT, Begaj T, Armstrong GW, Khurana RN, Parikh R. Private equity in ophthalmology and optometry: analysis of acquisitions from 2012 through 2019 in the United States. Ophthalmology 2020;127:445-55. DOI: https://doi.org/10.1016/j.ophtha.2020.01.007
Young A. Private equity ensures strong succession, peace of mind for some practices. Ocular Surgery News, 2021. Available at https://www.healio.com/news/ophthalmology/20211029/private-equity-ensures-strong-succession-peace-of-mind-for-some-practices.
Patel SN, Groth S, Sternberg Jr. P. The emergence of private equity in ophthalmology. JAMA Ophthalmol 2019;137:601-2. DOI: https://doi.org/10.1001/jamaophthalmol.2019.0964
Portney DS, Zhu Z, Chen EM, et al. COVID-19 and Use of Teleophthalmology (CUT Group): trends and diagnoses. Ophthalmology 2021;128:1483-5. DOI: https://doi.org/10.1016/j.ophtha.2021.02.010
Baum A, Kaboli PJ, Schwartz MD. Reduced in-person and increased telehealth outpatient visits during the COVID-19 pandemic. Ann Intern Med 2021;174:129-31. DOI: https://doi.org/10.7326/M20-3026
Satiani B, Davis CA. The financial and employment effects of coronavirus disease 2019 on physicians in the United States. J Vasc Surg 2020;72:1856-63. DOI: https://doi.org/10.1016/j.jvs.2020.08.031
Gill D. How low interest rates can hurt competition, and the economy. Chicago Booth Review—economics, 2019. Available at https://www.chicagobooth.edu/review/how-low-interest-rates-can-hurt-competition-and-economy.
Lexa FJ, Lexa FJ. Private equity-backed hospital investments and the impact of the coronavirus disease 2019 (COVID-19) epidemic. J Am Coll Radiol 2020;17:1049-52. DOI: https://doi.org/10.1016/j.jacr.2020.05.023
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157-60.
Schmidt H, Weintraub R, Williams MA, et al. Equitable allocation of COVID-19 vaccines in the United States. Nat Med 2021;27:1298-1307. DOI: https://doi.org/10.1038/s41591-021-01379-6
O’Donnell EM, Lelli GJ, Bhidya S, Casalino LP. The growth of private equity investment in health care: perspectives from ophthalmology. Health Aff (Millwood) 2020;39:1026-31. DOI: https://doi.org/10.1377/hlthaff.2019.01419
Gondi S, Song Z. Potential implications of private equity investments in health care delivery. JAMA 2019;321:1047-48. DOI: https://doi.org/10.1001/jama.2019.1077
Kirsh GM, Kapoor DA. Private equity and urology: an emerging model for independent practice. Urol Clin North Am 2021;48:233-44. DOI: https://doi.org/10.1016/j.ucl.2020.12.004
U.S. Department of Health and Human Services National Center for Health Workforce Analysis. National and regional projections of supply and demand for surgical specialty practitioners: 2013-2025. Available at https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/surgical-specialty-report.pdf.
American Academy of Ophthalmology. Recommendations for urgent and nonurgent patient care 2020. March 18, 2020. Available at https://www.aao.org/headline/new-recommendations-urgent-nonurgent-patient-care.
Wan KH, Lin TPH, Ko CN, Lam DSC. Impact of COVID-19 on ophthalmology and future practice of medicine. Asia Pac J Ophthalmol (Phila) 2020;9:279-80. DOI: https://doi.org/10.1097/APO.0000000000000305
Parke DW 2nd. Ophthalmology after coronavirus disease 2019 (COVID-19): transition back to patient care. JAMA Ophthalmol 2020;138:599-600. DOI: https://doi.org/10.1001/jamaophthalmol.2020.2004
Bruch JD, Gondi S, Song Z. Changes in hospital income, use, and quality associated with private equity acquisition. JAMA Intern Med 2020;180:1428-35. DOI: https://doi.org/10.1001/jamainternmed.2020.3552
Braun RT, Bond AM, Qian Y, Zhang M, Casalino LP. Private equity in dermatology: effect on price, utilization, and spending. Health Aff (Millwood) 2021;40:727-35. DOI: https://doi.org/10.1377/hlthaff.2020.02062
Parke DW 2nd. Corporatization in ophthalmology. Ophthalmology 2020;127:456-7. DOI: https://doi.org/10.1016/j.ophtha.2020.01.009
Kent C. Is a private equity deal right for you? (Pt 2). Review of Ophthalmology, May 10, 2018. Available at https://www.reviewofophthalmology.com/article/is-a-private-equity-deal-right-for-you-pt-2.
Chang RK, Joyce JJ, Castillo J, Ceja J, Quan P, Klitzner TS. Parental preference regarding hospitals for children undergoing surgery: a trade-off between travel distance and potential outcome improvement. Can J Cardiol 2004;20:877-82.
Landau JH, Novick TV, Dubois L, et al. Determination of patient preference for location of elective abdominal aortic aneurysm surgery. Vasc Endovascular Surg 2013;47:288-93. DOI: https://doi.org/10.1177/1538574413485648
Finlayson SR, Birkmeyer JD, Tosteson AN, Nease Jr RF. Patient preferences for location of care: implications for regionalization. Med Care 1999;37:204-9. DOI: https://doi.org/10.1097/00005650-199902000-00010
Ferry JH, Mehta JP, Puri CC. Congress renews push on investigating private equity investment in healthcare. 2021. Available at https://www.bradley.com/insights/publications/2021/03/congress-renews-push-on-investigating-private-equity-investment-in-healthcare.